vs
iHeartMedia, Inc.（IHRT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
iHeartMedia, Inc.的季度营收约是Revvity的1.5倍（$1.1B vs $772.1M），Revvity净利率更高（12.7% vs -3.7%，领先16.5%），Revvity同比增速更快（5.9% vs 0.8%），Revvity自由现金流更多（$161.8M vs $137.6M），过去两年iHeartMedia, Inc.的营收复合增速更高（18.8% vs 9.0%）
iHeartMedia是一家总部位于美国德克萨斯州圣安东尼奥的大众传媒企业，前身为清晰频道通信公司，1972年由劳里·梅斯与雷德·麦库姆斯创立，2008年由贝恩资本和托马斯·李合作伙伴公司通过杠杆收购完成私有化，目前是美国知名的传媒控股集团。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
IHRT vs RVTY — 直观对比
营收规模更大
IHRT
是对方的1.5倍
$772.1M
营收增速更快
RVTY
高出5.1%
0.8%
净利率更高
RVTY
高出16.5%
-3.7%
自由现金流更多
RVTY
多$24.2M
$137.6M
两年增速更快
IHRT
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $772.1M |
| 净利润 | $-41.9M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 7.6% | 14.5% |
| 净利率 | -3.7% | 12.7% |
| 营收同比 | 0.8% | 5.9% |
| 净利润同比 | -233.1% | 3.9% |
| 每股收益（稀释后） | $-0.25 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IHRTRVTY
| Q4 25 | $1.1B | $772.1M | ||
| Q3 25 | $997.0M | $698.9M | ||
| Q2 25 | $933.7M | $720.3M | ||
| Q1 25 | $807.1M | $664.8M | ||
| Q4 24 | $1.1B | $729.4M | ||
| Q3 24 | $1.0B | $684.0M | ||
| Q2 24 | $929.1M | $691.7M | ||
| Q1 24 | $799.0M | $649.9M |
净利润IHRTRVTY
| Q4 25 | $-41.9M | $98.4M | ||
| Q3 25 | $-66.3M | $46.7M | ||
| Q2 25 | $-83.5M | $53.9M | ||
| Q1 25 | $-281.2M | $42.2M | ||
| Q4 24 | $31.5M | $94.6M | ||
| Q3 24 | $-41.3M | $94.4M | ||
| Q2 24 | $-981.7M | $55.4M | ||
| Q1 24 | $-18.5M | $26.0M |
毛利率IHRTRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率IHRTRVTY
| Q4 25 | 7.6% | 14.5% | ||
| Q3 25 | -11.7% | 11.7% | ||
| Q2 25 | 3.8% | 12.6% | ||
| Q1 25 | -3.2% | 10.9% | ||
| Q4 24 | 9.3% | 16.3% | ||
| Q3 24 | 7.6% | 14.3% | ||
| Q2 24 | -97.9% | 12.4% | ||
| Q1 24 | -4.3% | 6.8% |
净利率IHRTRVTY
| Q4 25 | -3.7% | 12.7% | ||
| Q3 25 | -6.6% | 6.7% | ||
| Q2 25 | -8.9% | 7.5% | ||
| Q1 25 | -34.8% | 6.4% | ||
| Q4 24 | 2.8% | 13.0% | ||
| Q3 24 | -4.1% | 13.8% | ||
| Q2 24 | -105.7% | 8.0% | ||
| Q1 24 | -2.3% | 4.0% |
每股收益（稀释后）IHRTRVTY
| Q4 25 | $-0.25 | $0.86 | ||
| Q3 25 | $-0.43 | $0.40 | ||
| Q2 25 | $-0.54 | $0.46 | ||
| Q1 25 | $-1.84 | $0.35 | ||
| Q4 24 | $0.21 | $0.77 | ||
| Q3 24 | $-0.27 | $0.77 | ||
| Q2 24 | $-6.50 | $0.45 | ||
| Q1 24 | $-0.12 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $270.9M | $919.9M |
| 总债务越低越好 | $5.1B | — |
| 股东权益账面价值 | $-1.8B | $7.3B |
| 总资产 | $5.1B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IHRTRVTY
| Q4 25 | $270.9M | $919.9M | ||
| Q3 25 | $192.2M | $931.4M | ||
| Q2 25 | $235.9M | $991.8M | ||
| Q1 25 | $167.7M | $1.1B | ||
| Q4 24 | $259.6M | $1.2B | ||
| Q3 24 | $431.8M | $1.2B | ||
| Q2 24 | $364.7M | $2.0B | ||
| Q1 24 | $361.4M | $1.7B |
总债务IHRTRVTY
| Q4 25 | $5.1B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.1B | — | ||
| Q1 25 | $5.1B | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $5.2B | — | ||
| Q1 24 | $5.1B | — |
股东权益IHRTRVTY
| Q4 25 | $-1.8B | $7.3B | ||
| Q3 25 | $-1.8B | $7.4B | ||
| Q2 25 | $-1.7B | $7.6B | ||
| Q1 25 | $-1.6B | $7.6B | ||
| Q4 24 | $-1.4B | $7.7B | ||
| Q3 24 | $-1.4B | $7.9B | ||
| Q2 24 | $-1.4B | $7.9B | ||
| Q1 24 | $-398.6M | $7.8B |
总资产IHRTRVTY
| Q4 25 | $5.1B | $12.2B | ||
| Q3 25 | $5.1B | $12.1B | ||
| Q2 25 | $5.4B | $12.4B | ||
| Q1 25 | $5.3B | $12.4B | ||
| Q4 24 | $5.6B | $12.4B | ||
| Q3 24 | $5.8B | $12.8B | ||
| Q2 24 | $5.8B | $13.4B | ||
| Q1 24 | $6.8B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $156.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $137.6M | $161.8M |
| 自由现金流率自由现金流/营收 | 12.2% | 21.0% |
| 资本支出强度资本支出/营收 | 1.7% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $10.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流IHRTRVTY
| Q4 25 | $156.3M | $182.0M | ||
| Q3 25 | $-9.5M | $138.5M | ||
| Q2 25 | $6.8M | $134.3M | ||
| Q1 25 | $-60.9M | $128.2M | ||
| Q4 24 | $1.2M | $174.2M | ||
| Q3 24 | $102.8M | $147.9M | ||
| Q2 24 | $26.7M | $158.6M | ||
| Q1 24 | $-59.3M | $147.6M |
自由现金流IHRTRVTY
| Q4 25 | $137.6M | $161.8M | ||
| Q3 25 | $-32.8M | $120.0M | ||
| Q2 25 | $-13.2M | $115.5M | ||
| Q1 25 | $-80.7M | $112.2M | ||
| Q4 24 | $-24.2M | $149.8M | ||
| Q3 24 | $73.3M | $125.6M | ||
| Q2 24 | $5.6M | $136.6M | ||
| Q1 24 | $-80.9M | $129.7M |
自由现金流率IHRTRVTY
| Q4 25 | 12.2% | 21.0% | ||
| Q3 25 | -3.3% | 17.2% | ||
| Q2 25 | -1.4% | 16.0% | ||
| Q1 25 | -10.0% | 16.9% | ||
| Q4 24 | -2.2% | 20.5% | ||
| Q3 24 | 7.3% | 18.4% | ||
| Q2 24 | 0.6% | 19.7% | ||
| Q1 24 | -10.1% | 20.0% |
资本支出强度IHRTRVTY
| Q4 25 | 1.7% | 2.6% | ||
| Q3 25 | 2.3% | 2.6% | ||
| Q2 25 | 2.1% | 2.6% | ||
| Q1 25 | 2.4% | 2.4% | ||
| Q4 24 | 2.3% | 3.4% | ||
| Q3 24 | 2.9% | 3.3% | ||
| Q2 24 | 2.3% | 3.2% | ||
| Q1 24 | 2.7% | 2.7% |
现金转化率IHRTRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 0.04× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IHRT
| Broadcast Radio | $469.9M | 42% |
| Digital Non Podcast | $212.9M | 19% |
| Tradeand Barter Transactions | $124.4M | 11% |
| Networks | $118.2M | 10% |
| Audio And Media Services Group Segment | $78.9M | 7% |
| Sponsorship And Events | $71.4M | 6% |
| Advertising Trade And Barter Transactions | $23.7M | 2% |
| Other | $22.7M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
